BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2162576)

  • 21. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etiological factor of hepatocellular carcinoma in Italy.
    Stroffolini T
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):1-5. PubMed ID: 15756142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of malignant liver tumors].
    Rodella S; Picoco C
    Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma in sub-Saharan (tropical) Africa.
    Balint GA; Ghebrekidan H; Balint E
    Acta Med Hung; 1991; 48(3-4):177-87. PubMed ID: 1668371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic liver diseases as liver tumor precursors.
    Lata J
    Dig Dis; 2010; 28(4-5):596-9. PubMed ID: 21088408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS
    IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
    Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
    Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Ohata K; Hamasaki K; Toriyama K; Ishikawa H; Nakao K; Eguchi K
    J Gastroenterol Hepatol; 2004 Jun; 19(6):670-5. PubMed ID: 15151623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
    Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
    Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR; Oliveri F; Colombatto P; Bonino F
    Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma--a model of human cancer: clinico-pathological features, etiology and pathogenesis.
    Nayak NC
    Indian J Pathol Microbiol; 2003 Jan; 46(1):1-16. PubMed ID: 15027710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany].
    Erhardt A; Theobald I; Petry W; Röhrborn A; Heintges T; Wettstein M; Häussinger D
    Dtsch Med Wochenschr; 2002 Dec; 127(50):2665-8. PubMed ID: 12481236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
    Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
    Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.